Targeting pulmonary vascular endothelial cells for the treatment of respiratory diseases
Pulmonary vascular endothelial cells (VECs) are the main damaged cells in the pathogenesis of various respiratory diseases and they mediate the development and regulation of the diseases. Effective intervention targeting pulmonary VECs is of great significance for the treatment of respiratory diseas...
Saved in:
Main Authors: | Yi-Xuan Li (Author), Hong-Bo Wang (Author), Jing Li (Author), Jian-Bo Jin (Author), Jing-Bo Hu (Author), Chun-Lin Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
by: Rui Zhang, et al.
Published: (2020) -
mTORC2 Activation Mediated by Mesenchymal Stem Cell-Secreted Hepatocyte Growth Factors for the Recovery of Lipopolysaccharide-Induced Vascular Endothelial Barrier
by: Shan-Shan Meng, et al.
Published: (2021) -
Dual-wavelength pulsed dye laser inhibits proliferation and promotes apoptosis of hemangioma vascular endothelial cells
by: Qi DI, et al.
Published: (2024) -
Inhibition of microRNA-183 expression resists human umbilical vascular endothelial cells injury by upregulating expression of IRS1
by: Yingying Zhang, et al.
Published: (2019) -
Endothelial-Dependent and Independent Vascular Relaxation Effect of Tetrahydropalmatine on Rat Aorta
by: Zhong-Yan Zhou, et al.
Published: (2019)